Varda Shoshan-Barmatz Selected Research

Voltage-Dependent Anion Channel 1

3/2023	Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract.
1/2022	The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target.
1/2022	The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide.
1/2021	Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
1/2020	The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus.
12/2018	Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States.
1/2018	VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
1/2017	Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
12/2015	The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
10/2015	The mitochondrial voltage-dependent anion channel 1 in tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Varda Shoshan-Barmatz Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 05/2008
9	Inflammation (Inflammations) 04/2024 - 01/2018
8	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 04/2014
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 12/2015
5	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2012
4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 08/2010
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 01/2022
2	Diabetes Mellitus 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2019
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2018
2	Triple Negative Breast Neoplasms 09/2019 - 12/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 08/2010
2	Residual Neoplasm 12/2018 - 01/2018
2	Hypoxia (Hypoxemia) 01/2018 - 04/2012
2	Ganglion Cysts (Ganglion) 08/2005 - 07/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Virus Diseases (Viral Diseases) 09/2023
1	Diarrhea 01/2022
1	Hemorrhage 01/2022
1	Mesothelioma 01/2022
1	Pathologic Processes 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Foreign Bodies (Foreign Body) 06/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Obesity 01/2021
1	COVID-19 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Atrial Remodeling 12/2020
1	Myocardial Infarction 12/2020
1	Atrial Fibrillation 12/2020
1	Disease Progression 11/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019
1	Hyperglycemia 01/2019
1	Prediabetic State (Prediabetes) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Carcinogenesis 01/2018

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2010
14	Peptides (Polypeptides)IBA 04/2024 - 02/2009
12	Mitochondrial Proteins (Mitochondrial Protein)IBA 03/2024 - 01/2013
10	HexokinaseIBA 04/2024 - 05/2008
10	Voltage-Dependent Anion Channel 1IBA 03/2023 - 10/2015
10	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2010
9	Apoptosis Regulatory ProteinsIBA 01/2023 - 06/2009
5	EnzymesIBA 01/2022 - 05/2017
5	Transcription Factors (Transcription Factor)IBA 04/2020 - 08/2016
5	Cytochromes c (Cytochrome c)IBA 05/2017 - 05/2008
4	Phospholipids (Phosphatides)FDA LinkGeneric 04/2024 - 01/2018
4	Voltage-Dependent Anion ChannelsIBA 01/2018 - 05/2008
3	Adenosine Triphosphate (ATP)IBA 04/2024 - 04/2012
3	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 07/2017
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 04/2012
2	AnionsIBA 01/2022 - 06/2010
2	LipidsIBA 11/2021 - 01/2018
2	AntibodiesIBA 04/2020 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 01/2019
2	Superoxide DismutaseIBA 01/2019 - 08/2010
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2018 - 05/2017
2	Protein Isoforms (Isoforms)IBA 02/2009 - 05/2008
2	Retinaldehyde (Retinal)IBA 08/2005 - 07/2002
1	SurvivinIBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 04/2024
1	LigandsIBA 04/2024
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 04/2024
1	Interferon Regulatory FactorsIBA 09/2023
1	Pattern Recognition ReceptorsIBA 09/2023
1	PhytolIBA 03/2023
1	NF-kappa B (NF-kB)IBA 01/2022
1	AcidsIBA 01/2022
1	AsbestosIBA 01/2022
1	CytokinesIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	phosphatidylserine decarboxylaseIBA 01/2022
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2022
1	phosphatidylethanolamineIBA 11/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2021
1	Matrix Metalloproteinases (MMPs)IBA 06/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	AldosteroneIBA 12/2020
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 11/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2020
1	Ciliary Neurotrophic Factor (CNTF)IBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	ChromatinIBA 04/2020
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 04/2020
1	S-Adenosylmethionine (Ademetionine)IBA 04/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Mitochondrial DNA (mtDNA)IBA 12/2019
1	CholesterolIBA 07/2019
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	Chelating AgentsIBA 01/2018
1	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterIBA 01/2018
1	asparaginylendopeptidase (legumain)IBA 01/2018

Therapy/Procedure

14	Therapeutics 04/2024 - 05/2009
3	Drug Therapy (Chemotherapy) 01/2017 - 04/2012
1	Glycemic Control 01/2019